Submit Manuscript    >>    Login | Register

AF Literature Database


Search Knowledgebase by



Author last name starts with
B. Weijs(4)Asirvatham Samuel J SJ(3)Alan S. Go, MD(3)
Charlotte Eitel, MD(3)Ayman A. Hussein, MD(3)Charlotte Eitel(2)
Blanke Philipp P(2)Anné Wim W(2)Chamberlain AM(2)
Berenfeld Omer O(2)Caputo M(2)Chao TF(2)
Chen Peng-Sheng PS(2)Albert Nancy M NM(2)Andrade JG(2)
Akira Fukui, MD(2)Ajay K Jain(2)Cook G Elliott GE(2)
Botto GL(2)Bokeriia L A LA(2)Casella M(2)
Antonio Hernández-Madrid(2)Christian Sohns(2)Bengt Zöller(2)
Badger Troy J TJ(2)Baker William L WL(1)Bockeria Leo L(1)
Canabal Berlanga A A(1)Abe Hidetoshi H(1)Bhindi Ravinay R(1)
Cordero Alberto A(1)Chan PS(1)Benjamin A. Steinberg, MD;(1)
Aliyev Farid F(1)Bai Mei M(1)Capranzano Piera P(1)
Brooks Anthony G AG(1)Adam Oliver O(1)Berg Jenny J(1)
Alasady M(1)Alghamdi Abdullah A AA(1)Carmona Raj R(1)
Cerillo Alfredo Giuseppe AG(1)Choi Samjin S(1)Ananthapanyasut Wanwarat W(1)
Chung-Chuan Chou,MD*,*;(1)Akshay Bagai, MD, MHS(1)Chilukuri Karuna K(1)
Billeci Antonia M R AM(1)Aves Theresa T(1)


Literature Related to Harry Crijns, MD, PhD [Author]
 <<  <  1 2 3
  • Clinical and echocardiographic correlates of intra-atrial conduction delay


    Authors : Weijs B; de Vos CB; Tieleman RG; Pisters R; Cheriex EC; Prins MH;

    Affiliations : Corresponding author. Tel: +31 433875093; fax: +31 433875104, Email: cees.devos@yahoo.com

    Journal : Europace   (2011)

    Related Links: Pubmed | Publisher website


  • Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study


    Authors : Torp-Pedersen C; Crijns HJ; Gaudin C; Page RL; Connolly SJ; Hohnloser SH;

    Affiliations : Department of Cardiology, Gentofte Hospital, University of Copenhagen, 2009 Hellerup, Denmark. ctp@heart.dk Corresponding author. Tel: +45 39 97 87 13; fax: +45 70 20 12 82, Email: ctp@heart.dk

    Journal : EP Europace   (2011)

    Related Links: Pubmed | Publisher website


  • The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)


    Authors : European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH; ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P;

    Affiliations : St George's University of London, Cranmer Terrace, London SW17 ORE, UK. Tel: +44 20 8725 3414, Fax: +44 20 8725 3416, Email: jcamm@sgul.ac.uk The content of these European Society of Cardiology (ESC) Guidelines has been published for personal and educational use only. No commercial use is authorized. No part of the ESC Guidelines may be translated or reproduced in any form without written permission from the ESC. Permission can be obtained upon submission of a written request to Oxford University Press, the publisher of EP-Europace and the party authorized to handle such permissions on behalf of the ESC.

    Journal : EP Europace   (2011)

    Related Links: Pubmed | Publisher website


  • The occurrence of cardiovascular disease during 5-year follow-up in patients with idiopathic atrial fibrillation


    Authors :

    Affiliations : N/A

    Journal : N/A   (2012)

    Related Links: Pubmed | Publisher website


  • Transmural Conduction Is the Predominant Mechanism of Breakthrough During Atrial Fibrillation


    Authors :

    Affiliations : Correspondence to Ulrich Schotten, MD, PhD, Department of Physiology, University Maastricht, PO Box 616, 6200 MD Maastricht, The Netherlands. E-mail Schotten@maastrichtuniversity.nl

    Journal : N/A   (2013)

    Related Links: Pubmed | Publisher website


  • The occurrence of cardiovascular disease during 5-year follow-up in patients with idiopathic atrial fibrillation


    Authors :

    Affiliations : Corresponding author. Tel: +31 43 387 5093; fax: +31 4338 751 04, Email: b.weijs@mumc.nl

    Journal : N/A   (2012)

    Related Links: Pubmed | Publisher website


  • The occurrence of cardiovascular disease during 5-year follow-up in patients with idiopathic atrial fibrillation


    Authors :

    Affiliations : Corresponding author. Tel: +31 43 387 5093; fax: +31 4338 751 04, Email: b.weijs@mumc.nl

    Journal : N/A   (2012)

    Related Links: Pubmed | Publisher website


  • Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference


    Authors :

    Affiliations : University of Birmingham Centre for Cardiovascular Sciences and SWBH NHS Trust, Institute for Biomedical Research, 1st Floor, Room 136, Birmingham B15 2TT, UK University Hospital Münster, Münster, Germany AFNET, Germany CHU de Nancy, Nancy, France Duke University School of Medicine, Durham, NC, USA Fondazione Cardiocentro Ticino, Lugano, Switzerland St. Jude Medical, St. Paul, MN, USA Department of Cardiology, University of Leiden Medical Center, Leiden, NL, The Netherlands Department of Cardiology, Institution of Medical Science, Uppsala University, Uppsala, Sweden St. Antonius Hospital, Nieuwegein, The Netherlands University of Bologna, Bologna, Italy Odense University Hospital, Odense, Denmark Meda Pharma SAS, Paris, France University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany The Johns Hopkins Hospital, Baltimore, MD, USA University of Oxford, Oxford, UK University Hospital Maastricht, Maastricht, The Netherlands Daiichi Sankyo Europe GmbH, Munich, Germany University Duisburg-Essen, Essen, Germany Lankenau Institute for Medical Research, Wynnewood, PA, USA CRI—The Clinical Research Institute, Munich, Germany Ludwig Maximilian University, Munich, Germany University of Calgary/Libin, Calgary, Alberta, Canada Garibaldi-Nesima Hospital, Catania, Italy Bristol-Myers Squibb, Munich, Germany University Hospital Zurich, Zurich, Switzerland Faculté de Médecine Pitié-Salpętričre, Paris, France Charité Berlin, Berlin, Germany University Hospital Gasthuisberg, Leuven, Belgium Hôpital Cardologique du Haut-Lévęque and the Université Victor Segalen Bordeaux II, Bordeaux, France University of Lausanne, Lausanne, Switzerland Institute for Clinical and Experimental Medicine, Prague, Czech Republic Klinik St. Georg, Hanseatisches Herzzentrum, Hamburg, Germany Isar Herzzentrum, Munich, Germany Medtronic International Trading Sŕrl, Tolochenaz, Switzerland Hospital Clínic, University of Barcelona, Barcelona, Spain Pfizer Deutschland GmbH, Berlin, Germany Aarhus University Hospital, Aarhus, Denmark Städtisches Klinikum Brandenburg, Brandenburg, Germany Hacettepe University Faculty of Medicine, Ankara, Turkey Medizinische Universität Graz, Graz, Austria University of Belgrade, Belgrade, Serbia TU Dresden, Dresden, Germany Columbia University Medical Center, New York, NY, USA Bristol-Myers Squibb, Rueil-Malmaison, Paris, France Bayer Vital GmbH, Leverkusen, Germany St. Jude Medical, Zaventem, Belgium Boston Scientific, St. Paul, MN, USA Zentrum für Kardiologie am Klinikum Starnberg, Starnberg, Germany Institute of Cardiology, Warsaw, Poland Ettore Sansavini Health Science Foundation, Cotignola, Italy Ospedale dell'Angelo, Mestre-Venice, Venice, Italy Bayer Pharma AG, Berlin, Germany University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Sanofi Aventis Deutschland GmbH, Berlin, Germany University College Hospital, London, UK University Heart Center Hamburg, Hamburg, Germany St. George's Hospital Medical School, London, UK

    Journal : N/A   (2013)

    Related Links: Pubmed | Publisher website


  • The occurrence of cardiovascular disease during 5-year follow-up in patients with idiopathic atrial fibrillation


    Authors :

    Affiliations : Department of Cardiology, Maastricht University Medical Center & Cardiovascular Research Institute, PO Box 5800, Maastricht 6202 AZ, Groningen, The Netherlands Martini Hospital Groningen, The Netherlands

    Journal : N/A   (2012)

    Related Links: Pubmed | Publisher website


  • Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial


    Authors :

    Affiliations : Department of Cardiology, Maastricht University Medical Centre, PO Box 5800 6202 AZ, Maastricht, The Netherlands Department of Cardiology, J. W. Goethe University Hospital, Frankfurt, Germany McMaster University, Population Health Research Institute, Hamilton, Ontario, Canada Institute of Health, Science and Technology, Aalborg University, Aalborg Řst, Denmark Sanofi, Paris, France University of Washington, Seattle, USA

    Journal : N/A   (2013)

    Related Links: Pubmed | Publisher website


  • Transmural Conduction Is the Predominant Mechanism of Breakthrough During Atrial Fibrillation


    Authors :

    Affiliations : From the Department of Physiology, University Maastricht, Maastricht, The Netherlands (J.E., S.Z., D.L., B.M., S.V., A.v.H., M.A.A., U.S.); Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands (H.C.); and Department of Medicine, University Hospital Basel, Basel, Switzerland (J.E.).

    Journal : N/A   (2013)

    Related Links: Pubmed | Publisher website


Biosense Webster
event date
Introduction to AFib
Ablation Specialist

View Ablation Specialists